TipRanks
Go Ultimate55% OFF

Cocrystal Pharma (COCP) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Cdi-988, Snow Mountain VirusNorovirusphase1AndPhase2Not Yet RecruitingA Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain VirusSep 15, 2025―
Cc-42344Influenza APhase IICompletedInfluenza Viral Challenge Study of CC-42344 in Healthy ParticipantsNov 29, 2023―
Cdi-988Healthy VolunteersPhase ICompletedCDI-988 Safety Study in Healthy ParticipantsJul 28, 2023―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cocrystal Pharma (COCP) have in its pipeline
Cocrystal Pharma COCP is currently developing the following drugs: Cdi-988, Snow Mountain Virus, Cc-42344, Cdi-988. These drug candidates are in various stages of clinical development as the company works toward FDA approval.